Thomas G Martin

5PUBLICATIONS
10CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Gene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Sep 01, 2026
GPRC5D-targeting bispecific and trispecific antibodies in multiple myeloma: Current evidence and emerging strategies.

|Jan 04, 2026
Efficacy and safety of teclistamab in triple-class exposed relapsed/refractory multiple myeloma: Pooled findings from three clinical cohorts and a retrospective cohort.

Thomas G Martin, María-Victoria Mateos, Jun Ho Yi

|Nov 14, 2023
Incidence, timing, and management of infections in patients receiving teclistamab for the treatment of relapsed/refractory multiple myeloma in the MajesTEC-1 study.

Ajay K Nooka, Cesar Rodriguez, María Victoria Mateos

|Mar 30, 2023
Detailed overview of incidence and management of cytokine release syndrome observed with teclistamab in the MajesTEC-1 study of patients with relapsed/refractory multiple myeloma.

Thomas G Martin, Maria Victoria Mateos, Ajay Nooka

|Mar 18, 2021
Phase 1b trial of isatuximab, an anti-CD38 monoclonal antibody, in combination with carfilzomib as treatment of relapsed/refractory multiple myeloma.

Thomas G Martin, Nina Shah, Joshua Richter

Pageof 1

Frequent Collaborators

3 joint publications

Ajay Nooka

1 joint publications

Nina Shah

1 joint publications

Sundar Jagannath

1 joint publications

Ajai Chari